Lung cancer screening with low-dose chest computed tomography (CT) may reveal more than simply lung cancer. According to new research published in CMAJ (Canadian Medical Association Journal), these CTs can detect coronary artery calcium, a high risk factor for coronary artery disease (CAD), in patients without cardiac symptoms.
“Lung cancer screening, although primarily geared towards reducing deaths from lung cancer, also has an opportunity to help tackle the second most common cause of premature death in middle-aged adults, through the identification and risk stratification of coronary atherosclerosis,” writes Dr. Gary Small, University of Ottawa Heart Institute, Ottawa, Ontario, with coauthors.
Coronary artery calcium was discovered in 83% (1232) of the 1486 people screened for lung cancer between March 2017 and November 2018 as part of the Ontario Health Lung Cancer Screening Pilot for People at High Risk, with high levels in 30% (439). More than half of the patients (52% were men), the average age was 66 years, and 68% (1017) were current smokers.
Because lung cancer is the main cause of cancer deaths in Canada, screening programs across the country have implemented low-dose CT for those at risk of lung cancer. These CTs can also easily detect coronary calcification, which is a sign of coronary artery disease, the leading cause of cardiac death.
The success of this pilot program will depend on how clinicians interpret and manage coronary artery calcium readings. However, clinicians must be mindful that there may be negative consequences, such as inappropriate examination following coincidental detection.
“If appropriate therapeutic responses are instituted, lung CT findings could affect survival from 2 leading causes of death: lung cancer and coronary artery disease,” the authors write.
For more information: Caires, M. C., et al. (2024) Prognostic importance of extensive coronary calcium on lung cancer screening chest computed tomography. CMAJ. doi.org/10.1503/cmaj.231602.
more recommended stories
Alzheimer’s Disease Study Questions Glucosamine SafetyKey Summary New research published in.
WHO: Andes Hantavirus Not a COVID-19-Level ThreatKey Summary Andes hantavirus has drawn.
Mazdutide Shows Significant Weight Loss in Phase 3 TrialKey Summary Mazdutide, a dual GLP-1.
Genetic Screening Project Launches for Brazilian ParentsKey Summary Brazil is launching the.
Fatherhood Linked to Lower Mortality Risk in Black MenKey Summary A new longitudinal study.
CAR T-Cell Therapy Offers Hope for Highly Sensitized PatientsKey Summary Researchers at the University.
Strength Training May Reduce Mortality Risk, Study FindsKey Summary A 30-year study involving.
New Alzheimer’s Drugs Raise Questions for RegulatorsKey Points Summary New Alzheimer’s drugs.
Gut Keystone Bacteria: How Diet Shapes Microbiome HealthKey Takeaways Researchers are identifying “gut.
Pregnancy Nausea May Signal Anxiety and Depression RiskKey Summary A prospective study published.

Leave a Comment